Results 71 to 80 of about 6,033 (178)
One year follow up effect of renal sympathetic denervation in patients with resistant hypertension
BACKGROUND: Resistant hypertension is a common clinical problem of blood pressure that is not controlled despite the simultaneous application of multiple antihypertensive agents.
Masoud Pourmoghaddas +9 more
doaj
We recently demonstrated that cilnidipine, an L/N-type calcium channel blocker, elicits protective effects against glomerular podocyte injury, in particular, in obese hypertensive rats that express the N-type calcium channel (N-CC).
Bai Lei +10 more
doaj +1 more source
Ablação da atividade simpática renal para tratamento da hipertensão arterial resistente
Resumo: A hipertensão arterial é um importante fator de risco cardiovascular e apesar dos inúmeros avanços na terapêutica farmacológica, existe ainda uma percentagem importante de doentes que são resistentes.
Pedro de Araújo Gonçalves +13 more
doaj +1 more source
Percutaneous Renal Sympathetic Denervation
Drug-resistant arterial hypertension is defined as the high blood bressure pressure that remains uncontrolled, despite treatment with at least three drugs at the maximum tolerated doses. These patients have a 50% higher chance of developing adverse events when compared to those with controlled blood pressure.
openaire +1 more source
Background The renal sympathetic nervous system modulates systemic blood pressure, cardiac performance, and renal function. Pathological increases in renal sympathetic nerve activity contribute to the pathogenesis of heart failure with preserved ejection
Jake E. Doiron +12 more
doaj +1 more source
Acute urinary bladder distension (AUBD) can activate bladder mechanical afferent and renal sympathetic nerves, which contributes to renal vasoconstriction.
Show-Shing Chen +4 more
doaj +1 more source
Renal sympathetic nerve activity after catheter-based renal denervation
Background Catheter-based renal sympathetic denervation (RDN) has been considered a potential treatment for therapy resistant hypertension (RHT). However, in a randomized placebo-controlled trial, RDN did not lead to a substantial blood pressure (BP ...
Linn C. Dobrowolski +8 more
doaj +1 more source
Increased central sympathetic drive is a hallmark of a number of important and common clinical conditions including essential hypertension, insulin resistance, heart failure, and chronic kidney disease.
Markus Peter Schlaich +6 more
doaj +1 more source
Future of Renal Sympathetic Denervation in the Treatment of Hypertension
In this issue of the Journal, Sardar et al. (1) report the results of a meta-analysis evaluating the blood pressure (BP) response to renal sympathetic denervation (RSD) in 6 sham-controlled randomized clinical trials including 3 recently published trials and totaling 977 patients.
Kjeldsen, Sverre E. +2 more
openaire +3 more sources

